Contact this trialFirst, we need to learn more about you.
Cyclodextrin
IV VTS-270 for Niemann-Pick Disease
Recruiting1 awardPhase 1 & 2
Saint Louis, Missouri
This trial is testing a drug to see if it's effective in treating acute liver disease in infants with Niemann-Pick disease, type C (NPC), which is a rare, fatal disease that causes progressive degeneration of the nervous system.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service